Literature DB >> 32564019

Neutral Lipid Storage Disease Associated with the PNPLA2 Gene: Case Report and Literature Review.

Makoto Samukawa1, Naoko Nakamura2, Makito Hirano3, Miyuki Morikawa1, Hanami Sakata1, Ichizo Nishino4, Rumiko Izumi2, Naoki Suzuki2, Hiroshi Kuroda2, Kensuke Shiga5,6, Kazumasa Saigoh1, Masashi Aoki2, Susumu Kusunoki1.   

Abstract

Mutations in the PNPLA2 gene cause neutral lipid storage disease with myopathy (NLSDM) or triglyceride deposit cardiomyovasculopathy. We report a detailed case study of a 53-year-old man with NLSDM. The PNPLA2 gene was analyzed according to the reported method. We summarized the clinical, laboratory, and genetic information of 56 patients, including our patient and 55 other reported patients with homozygous or compound heterozygous mutations in the PNPLA2 gene. We found a novel homozygous mutation (c.194delC) in the PNPLA2 gene that resulted in frameshift. The patient suffered from normal-tension glaucoma and pulmonary cysts, symptoms that are relatively common in the elderly but were not previously reported for this disease. Our summary confirmed that Jordan's anomaly, polymorphonuclear leukocytes with lipid accumulation, was the most consistent finding of this disease. Because this disease is potentially treatable, our results may help rapid and correct diagnosis.
© 2020 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Genotype-phenotype correlation; Glaucoma; Neutral lipid storage disease with myopathy; PNPLA2; Pulmonary cysts; Triglyceride deposit cardiomyovasculopathy

Mesh:

Substances:

Year:  2020        PMID: 32564019      PMCID: PMC7592920          DOI: 10.1159/000508346

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  16 in total

1.  Effects of bezafibrate treatment in a patient and a carrier with mutations in the PNPLA2 gene, causing neutral lipid storage disease with myopathy.

Authors:  Tineke van de Weijer; Bas Havekes; Lena Bilet; Joris Hoeks; Lauren Sparks; Madeleen Bosma; Sabina Paglialunga; Johanna Jorgensen; Mirian C H Janssen; Gert Schaart; Hans Sauerwein; Joep L Smeets; Joachim Wildberger; Rudolf Zechner; Vera B Schrauwen-Hinderling; Matthijs K C Hesselink; Patrick Schrauwen
Journal:  Circ Res       Date:  2013-03-01       Impact factor: 17.367

2.  Neutral lipid storage disease with myopathy and dropped head syndrome. Report of a new variant susceptible of treatment with late diagnosis.

Authors:  Mary A Garcia; Jorge A Rojas; Sonia P Millán; Adriana A Flórez
Journal:  J Clin Neurosci       Date:  2018-10-22       Impact factor: 1.961

3.  The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy.

Authors:  Judith Fischer; Caroline Lefèvre; Eva Morava; Jean-Marie Mussini; Pascal Laforêt; Anne Negre-Salvayre; Mark Lathrop; Robert Salvayre
Journal:  Nat Genet       Date:  2006-12-24       Impact factor: 38.330

4.  Multiple transcripts of the human Cu,Zn superoxide dismutase gene.

Authors:  M Hirano; W Y Hung; N Cole; A C Azim; H X Deng; T Siddique
Journal:  Biochem Biophys Res Commun       Date:  2000-09-16       Impact factor: 3.575

5.  DNA single-strand break repair is impaired in aprataxin-related ataxia.

Authors:  Makito Hirano; Aya Yamamoto; Toshio Mori; Li Lan; Taka-aki Iwamoto; Masashi Aoki; Keiji Shimada; Yoshiko Furiya; Shingo Kariya; Hirohide Asai; Akira Yasui; Tomohisa Nishiwaki; Kyoko Imoto; Nobuhiko Kobayashi; Takao Kiriyama; Tetsuya Nagata; Noboru Konishi; Yasuto Itoyama; Satoshi Ueno
Journal:  Ann Neurol       Date:  2007-02       Impact factor: 10.422

6.  Identification of a novel phosphorylation site in adipose triglyceride lipase as a regulator of lipid droplet localization.

Authors:  Xitao Xie; Paul Langlais; Xiaodong Zhang; Bradlee L Heckmann; Alicia M Saarinen; Lawrence J Mandarino; Jun Liu
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-05-06       Impact factor: 4.310

7.  The lack of the C-terminal domain of adipose triglyceride lipase causes neutral lipid storage disease through impaired interactions with lipid droplets.

Authors:  Kunihisa Kobayashi; Toyoshi Inoguchi; Yasutaka Maeda; Naoki Nakashima; Asako Kuwano; Erina Eto; Noriko Ueno; Shuji Sasaki; Fumi Sawada; Masakazu Fujii; Yuka Matoba; Shinji Sumiyoshi; Hisaya Kawate; Ryoichi Takayanagi
Journal:  J Clin Endocrinol Metab       Date:  2008-04-29       Impact factor: 5.958

8.  Neutral lipid storage disease with myopathy: Further phenotypic characterization of a rare PNPLA2 variant.

Authors:  Caitlin S Latimer; Jennifer Schleit; Adam Reynolds; Desiree A Marshall; Benjamin Podemski; Leo H Wang; Luis F Gonzalez-Cuyar
Journal:  Neuromuscul Disord       Date:  2018-04-19       Impact factor: 4.296

9.  Distal lipid storage myopathy due to PNPLA2 mutation.

Authors:  Aya Ohkuma; Ikuya Nonaka; May Christine V Malicdan; Satoru Noguchi; Satoru Ohji; Kyoichi Nomura; Hideo Sugie; Yukiko K Hayashi; Ichizo Nishino
Journal:  Neuromuscul Disord       Date:  2008-07-26       Impact factor: 4.296

10.  Peripheral leukocyte anomaly detected with routine automated hematology analyzer sensitive to adipose triglyceride lipase deficiency manifesting neutral lipid storage disease with myopathy/triglyceride deposit cardiomyovasculopathy.

Authors:  Akira Suzuki; Hironori Nagasaka; Yasuhiro Ochi; Kazuhiro Kobayashi; Hiroshi Nakamura; Daisaku Nakatani; Satoshi Yamaguchi; Shinobu Yamaki; Atsushi Wada; Yoshihisa Shirata; Shu-Ping Hui; Tatsushi Toda; Hiroshi Kuroda; Hitoshi Chiba; Ken-Ichi Hirano
Journal:  Mol Genet Metab Rep       Date:  2014-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.